Omalizumab effects rapid, often complete, clearance of refractory bullous pemphigoidApril 4, 2017Wounds
Anthony Fauci faces the ‘perpetual challenge’ of emerging infectionsMarch 31, 2017Infectious DiseasesRare DiseasesBusiness of Medicine
FDA grants breakthrough therapy status to rituximab for pemphigus vulgarisMarch 29, 2017Autoimmune DiseasesWounds
Justice Department joins lawsuit alleging massive Medicare fraud by UnitedHealthMarch 29, 2017Business of Medicine
